Recombinant Human soluble VEGFR1/FLT1 (D1-7)

Molecule:

VEGFR1/FLT1

Species:

Human

Cat. No.:

CRF105C pdf (datasheet)

Quantity/Size:

1.0 mg

Description:

Background: Endothelial cells express three different vascular endothelial growth factor (VEGF) receptors, belonging to the family of receptor tyrosine kinases (RTKs). They are named VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3 (Flt-4). Their express

EC number:

2.7.10.1

Data PDF:

CRF105

Source:

Insect cells

Molecular Weight:

130 kDa

Physical State:

Lyophilized

Formulation:

Lyophilized from a sterile filtered solution in PBS.

Purity:

>95% by SDS-PAGE analysis.

Biological Activity:

ED50: Typically 10-30 ng/ml (Determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells).

Endotoxin Level:

<0.1 ng/�g

Reconstitution:

Centrifuge vial prior to opening. Reconstitute in PBS or medium to a concentration of ?50 ?g/ml. The solution can then be further diluted in other aqueous buffers.

Storage/Stability:

Lyophilized protein is stable at -20℃C to -80℃C for >6 months. After reconstitution, aliquot and store at -20℃C. Avoid repeated freeze-thaw cycles.